Solubility Enhancement Techniques for Poorly Water-Soluble Drugs

FACTORS AFFECTING SOLUBILITY

Solubility of a drug depends on several physical, chemical, and environmental factors. Understanding these factors helps in selecting the correct solubility enhancement method.

1. Drug particle size:

Particle size has a direct impact on solubility. Smaller particles have a larger surface area, which increases the contact with solvent.

b) Nature of solvent as well as solute:

Both the solvent's and the solute's properties depend on concentration and temperature. At room temperature, two hundred gram of zinc chloride may dissolve one gram of lead (II) chloride in one hundred gram of water.

c) The size of molecules:

As the molecular sizes of particles change, so does their solubility. Because the solvent molecules find it more difficult to fully encase molecules, a material becomes less soluble as its molecular weight and size grow.

 d) Temperature:

Solubility is influenced by temperature. When the dissolution process absorbs energy (endothermic), solubility tends to increase with rising temperature.

e) Pressure:

While a gaseous solute's solubility increases with increasing pressure and decreases with decreasing pressure, the solubility of a solid or liquid solute remains constant when pressure changes.

2. CLASSIFICATION OF SOLUBILITY

2.1 As per USP

The United States Pharmacopoeia (USP) classifies solubility based on the parts of solvent required to dissolve one part of solute.

USP Solubility Categories

2.2 As per BCS

Biopharmaceutics classification system (BCS)

The US Food and Drug Administration (FDA) created the Biopharmaceutics Classification System (BCS). categorizes pharmaceuticals into four classes according on their solubility and permeability characteristics

3. IMPORTANCE OF SOLUBILITY

Oral bioavailability depends on factors like solubility, membrane permeability, dissolution rate, metabolism before reaching systemic circulation, and elimination. Among these, poor solubility and low permeability are the main reasons for reduced bioavailability.

Solubility is essential for achieving effective drug levels in the body and is important for both oral and parenteral formulations. Drugs with low solubility often require higher doses.

The low water solubility of many medications results in sluggish absorption, leading to insufficient and inconsistent bioavailability, as well as potential damage to the gastrointestinal mucosa.

1. To Improve Drug Absorption (Bioavailability)

For any drug to work, it must first dissolve in the gastrointestinal fluids. Low solubility = low dissolution = low absorption

Drugs remain undissolved and pass through the body without showing effect. When solubility is enhanced, the drug dissolves faster, leading to better absorption into the bloodstream.

 2. To Reduce the Dose and Improve Patient Compliance

Poorly soluble drugs often require high doses to achieve therapeutic levels. High doses can result in increased side effects poor patient compliance more burden on the body.

3. To Improve the Onset of Action

A drug that dissolves slowly takes a longer time to show its effect. By improving solubility: the drug dissolves rapidly absorption becomes faster onset of action is quicker

4. To Achieve Consistent and Predictable Drug Action

Poor solubility causes unpredictable drug absorption, which leads to irregular plasma concentration inconsistent therapeutic effect dose-to-dose variation in patients Solubility enhancement ensures uniform dissolution and absorption, resulting in better therapeutic predictability.

5. To Improve Stability and Shelf-Life of Drug Products

Convert drugs into stable amorphous forms prevent crystallization increase overall stability of dosage forms.

5. TECHNIQUES FOR SOLUBILITY ENHANCEMENT

Low water solubility and poor bioavailability are major challenges in pharmaceutical development, especially for oral drugs. Improving solubility is essential for better absorption, but it is often difficult. Although various methods exist, their effectiveness depends on drug properties, excipients, and dosage form. Many techniques are complex and costly, and they do not always achieve optimal bioavailability.

The selection of procedures is based on specific factors like the characteristics of the medicine being considered, the qualities of the selection of excipients, and the type of the planned dosage form. Orally given medications achieve full absorption only when they have sufficient solubility in the stomach and exhibit excellent bioavailability.

In the process of developing new medications, it may be very difficult to increase a drug's solubility and, therefore, its oral bioavailability, especially for oral drug delivery systems. There are several methods documented in literature to improve the solubility of drugs that have low water solubility.

a) Particle Size Reduction:

Bioavailability is closely related to particle size, as reducing particle size increases surface area and improves drug dissolution. Techniques like milling (e.g., jet mills and colloid mills), micronization, and nanosuspension are used for particle size reduction. However, these methods do not increase the drug’s saturation solubility and are less suitable for high-dose drugs.

Advantages of particle size reduction:

1. Liquid forms can be rapidly developed for early-stage testing (pre-clinical) that can be converted into solids for later clinical development.
2. Typically, low excipient to drug ratios is required.

Disadvantages of particle size reduction:

1. Due to the high surface charge on discrete small particles, there is a strong tendency for particle agglomeration.
2. Technically, the development of sterile intravenous formulations is even more challenging.

Nanonization:

Various nanonization strategies have emerged to increase the dissolution rates and bioavailability of numerous drugs that are poorly soluble in water. Nanonization broadly refers to the study and use of materials and structures at the nanoscale level of approximately 100 nm or less.

2. Co-solvency:

It is also known as “Solvent blending”. It enhances the solubility of a poorly water-soluble drug by the addition of water-miscible solvent in which drug has good solubility by reducing the interfacial tension.

Advantages of co-solvency:

1. Has large solubilization capacity for poorly soluble drugs, simple and rapid to formulate, produce and evaluate.

Disadvantages of co-solvency:

1. Toxicity and tolerability related with the level of solvent administered has to be considered.

Hydrotrophy:

Hydrotrophy is a solubilization process whereby the addition of a large amount of the second solute increases the aqueous solubility of another solute. Solute consists of alkali metal salts of various organic acids. Hydrotropic agents are ionic organic salts.

3. pH Adjustment:

Poorly water-soluble drugs with parts of the molecule that can be base or acid may potentially be dissolved in water by applying a pH change. pH adjustment can in principle be used for both oral and parenteral administration. Upon intravenous administration, the poorly soluble drug may be precipitate because blood is a strong buffer with pH between 7.2 – 7.4.

 Advantages of pH Adjustment:

1. Simple to formulate and analyse.
2. Simple to produce and fast track.

Disadvantages of pH Adjustment:

• Tolerability and toxicity (local and systemic) related to the use of a non-physiological pH and extreme pHs.

Sono crystallization:

Recrystallization of poorly soluble materials using liquid solvents and antisolvents has also been employed successfully to reduce particle size. The novel approach for particle size reduction based on crystallization by using ultrasound is Sono crystallization.

Sono crystallization utilizes ultrasound power characterized by a frequency range of 20-100 kHz for inducing crystallization.

6. CONCLUSION